SINGAPORE & SAN CARLOS, Calif.--(BUSINESS WIRE)--Engine Biosciences (“Engine”) today announced the successful completion of an oversubscribed $43 million Series A funding round. Engine identifies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback